Skip to content

Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS

Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking Performance and Quality of Life in Individuals With Multiple Sclerosis: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02606604
Acronym
MSCycling
Enrollment
15
Registered
2015-11-17
Start date
2015-11-30
Completion date
2017-07-31
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Functional Electrical Stimulation, Cycling

Brief summary

This study will seek to determine the benefits that FES-LE cycling has over cycling alone on walking performance and quality of life in people with multiple sclerosis.

Detailed description

Functional Electrical Stimulation (FES) is a rehabilitation tool that stimulates nerves via electrical current, causing muscles to contract. When FES is appled to leg muscles during stationary cycling the legs move in a fixed rhythmical pattern. Previous studies have demonstrated that FES during cycling is a safe and effective exercise for individuals recovering from spinal cord injury or stroke, but few have applied this tool to a progressive disorder, such as multiple sclerosis (MS). The aim of this study is to assess the immediate and short-term effect of an 8-week training program comparing FES lower extremity cycling to cycling without FES. Twenty volunteers with MS will participate. They will be randomly assigned to a training group. This study examine the effects of training on quality of life, endurance, walking speed, and step quality. Participants will sign an informed consent and complete a questionnaire that includes medical history and demographic data. Before training, immediately after training finishes and one month after training, self-report questionnaires, timed walking tests will be completed. During the walking tests, step quality and speed will be measured with a sensor that is worn on a belt

Interventions

DEVICERT 300: Lower Extremity Cycling

Individuals will be randomly assigned to either the FES cycling or cycling only group and will perform lower extremity cycling. Individuals will participate in an interval training cycling program 3 times per week for 8 weeks.

Sponsors

Stony Brook University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Medical Diagnosis of MS * Patient-determined Disease Steps score between 3.0 and 6.0 inclusive * Ability to attend training sessions 3 times per week for an 8-10 week period * Passing a submaximal exercise test * Adequate hip range of motion (at least 110 degrees) * Adequate knee range of motion (10-90 degrees)

Exclusion criteria

* Cognitive deficits that would interfere in ability to sign consent and understand the procedures for the study. * History or presence of other neurological pathologies that interfere with movement * Received physical therapy within the last 4 weeks prior to the study * History of an acute exacerbation of their MS symptoms within 4 weeks prior to the study * Immunosuppressive or steroid therapy within the past 4 weeks * Significant spasticity in the legs that interferes with the cycling motion * History of congestive heart failure * Coronary Artery Disease * Uncontrolled Hypertension * History of epilepsy or seizures * Cardiac demand pacemaker or implanted defibrillator * Unhealed fractures in the legs * Pressure sores or open wounds on the legs * Pregnant or trying to conceive

Design outcomes

Primary

MeasureTime frameDescription
Gait Velocity: Timed WalkingBaselineGait velocity was reported in meters/second based on a 25 foot walk test called the Timed 25 foot Walk Test. Faster gait speeds are better outcomes.

Secondary

MeasureTime frameDescription
Self-reported Fatigue Using Modified Fatigue Impact ScaleBaselineThe Modified Fatigue Impact Scale is a 21 item self-report questionnaire that takes 5-10 minutes to complete. It uses a 5-point likert scale to rate the patient's perception of how Multiple Sclerosis related fatigue affects an individual's life on an everyday basis. It contains three subscales that include: cognitive, physical, and psychosocial dimensions. Scores on the subscales can be analyzed individually or as a summed score to give an overall fatigue score. Higher scores indicate a greater impact of fatigue. The minimum score is a 0 and the maximum score is 81.
Self-reported Walking Using 12 Item Multiple Sclerosis Walking ScaleBaselineThe Multiple Sclerosis Walking Scale is a 12-item self-report questionnaire that takes approximately 10 minutes to complete and reflects a persons' perception of the impact that multiple sclerosis has on walking ability during the past 2 weeks. Each of the items scored ranges from 1 to 5, in which higher scores indicate a greater impact of multiple sclerosis on their walking. Scores on the 12 items are summed. To transform to a 0-100 scale, the minimum score of 12 is subtracted from the sum; the result is divided by 48 and then multiplied by 100. The lowest score is 0 and the highest score is 100. Higher scores mean a worse outcome.
Overall Self-reported Quality of Life Using Multiple Sclerosis Quality of Life- 54BaselineThe Multiple Sclerosis Quality of Life-54 is a self-report quality of life questionnaire. It measures health-related quality of life using both generic and disease-specific measures and was constructed by experts in the field. There is no overall score for this scale since it contains 12 subscales, two summary scores, and two single-item measures. The quality of life subscale was the chosen outcome measure reported below. The scores range from 0-100. Higher scores on the scale notes improved outcome.

Countries

United States

Participant flow

Recruitment details

PWMS were recruited from various sources from including: physician practices, physical therapy practices, support groups, web postings, email, fitness centers, and personal communication. Recruitment was from June 2015 - July 2017.

Pre-assignment details

Participants were excluded from the study if they did not meet the inclusion/exclusion criteria.

Participants by arm

ArmCount
FES Cycling
The intervention consists of electrical stimulation to five lower extremity muscle groups (quadricep, hamstring, anterior tibialis, gluteal, and gastrocnemius muscle groups) while cycling for 45 minutes, 3 times per week for 8 weeks. Outcome measures will be collected at baseline, 4 weeks, 8 weeks and 4 weeks after training is completed).
7
Cycling Only
The intervention consists of lower extremity cycling for 45 minutes, 3 times per week for 8 weeks. Electrical stimulation will not be applied to any muscles. Outcome measures will be collected at baseline, 4 weeks, 8 weeks and 4 weeks after training is completed.
7
Total14

Baseline characteristics

CharacteristicFES CyclingCycling OnlyTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants0 Participants3 Participants
Age, Categorical
Between 18 and 65 years
4 Participants7 Participants11 Participants
Age, Continuous59.71 years
STANDARD_DEVIATION 7.54
47.51 years
STANDARD_DEVIATION 8.97
53.64 years
STANDARD_DEVIATION 10.16
Patient Determined Disease Steps (PPDS)3.71 units on a scale
STANDARD_DEVIATION 0.76
3.71 units on a scale
STANDARD_DEVIATION 1.11
3.71 units on a scale
STANDARD_DEVIATION 0.91
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
7 Participants7 Participants14 Participants
Sex: Female, Male
Female
3 Participants5 Participants8 Participants
Sex: Female, Male
Male
4 Participants2 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 70 / 7
other
Total, other adverse events
0 / 70 / 7
serious
Total, serious adverse events
0 / 70 / 7

Outcome results

Primary

Gait Velocity: Timed Walking

Gait velocity was reported in meters/second based on a 25 foot walk test called the Timed 25 foot Walk Test. Faster gait speeds are better outcomes.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
FES CyclingGait Velocity: Timed Walking1.33 meters/secondStandard Error 1.39
Cycling OnlyGait Velocity: Timed Walking1.4 meters/secondStandard Error 1.48
Primary

Gait Velocity: Timed Walking

Gait velocity was reported in meters/second based on a 25 foot walk test called the Timed 25 foot Walk Test. Faster gait speeds are better outcomes.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
FES CyclingGait Velocity: Timed Walking1.39 meters/secondStandard Error 0.18
Cycling OnlyGait Velocity: Timed Walking1.45 meters/secondStandard Error 0.18
Primary

Gait Velocity: Timed Walking

Gait velocity was reported in meters/second based on a 25 foot walk test called the Timed 25 foot Walk Test. Faster gait speeds are better outcomes.

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
FES CyclingGait Velocity: Timed Walking1.44 meters/secondStandard Error 0.18
Cycling OnlyGait Velocity: Timed Walking1.42 meters/secondStandard Error 0.18
Primary

Gait Velocity: Timed Walking

Gait velocity was reported in meters/second based on a 25 foot walk test called the Timed 25 foot Walk Test. Faster gait speeds are better outcomes.

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
FES CyclingGait Velocity: Timed Walking1.34 meters/secondStandard Error 0.18
Cycling OnlyGait Velocity: Timed Walking1.42 meters/secondStandard Error 0.18
Secondary

Overall Self-reported Quality of Life Using Multiple Sclerosis Quality of Life- 54

The Multiple Sclerosis Quality of Life-54 is a self-report quality of life questionnaire. It measures health-related quality of life using both generic and disease-specific measures and was constructed by experts in the field. There is no overall score for this scale since it contains 12 subscales, two summary scores, and two single-item measures. The quality of life subscale was the chosen outcome measure reported below. The scores range from 0-100. Higher scores on the scale notes improved outcome.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
FES CyclingOverall Self-reported Quality of Life Using Multiple Sclerosis Quality of Life- 5470.95 score on a scaleStandard Error 6.28
Cycling OnlyOverall Self-reported Quality of Life Using Multiple Sclerosis Quality of Life- 5460.95 score on a scaleStandard Error 6.28
Secondary

Overall Self-reported Quality of Life Using Multiple Sclerosis Quality of Life- 54

The Multiple Sclerosis Quality of Life-54 is a self-report quality of life questionnaire. It measures health-related quality of life using both generic and disease-specific measures and was constructed by experts in the field. There is no overall score for this scale since it contains 12 subscales, two summary scores, and two single-item measures. The quality of life subscale was the chosen outcome measure reported below. The scores range from 0-100. Higher scores on the scale notes improved outcome.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
FES CyclingOverall Self-reported Quality of Life Using Multiple Sclerosis Quality of Life- 5461.19 score on a scaleStandard Error 6.28
Cycling OnlyOverall Self-reported Quality of Life Using Multiple Sclerosis Quality of Life- 5457.62 score on a scaleStandard Error 6.28
Secondary

Self-reported Fatigue Using Modified Fatigue Impact Scale

The Modified Fatigue Impact Scale is a 21 item self-report questionnaire that takes 5-10 minutes to complete. It uses a 5-point likert scale to rate the patient's perception of how Multiple Sclerosis related fatigue affects an individual's life on an everyday basis. It contains three subscales that include: cognitive, physical, and psychosocial dimensions. Scores on the subscales can be analyzed individually or as a summed score to give an overall fatigue score. Higher scores indicate a greater impact of fatigue. The minimum score is a 0 and the maximum score is 81.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
FES CyclingSelf-reported Fatigue Using Modified Fatigue Impact Scale42 score on a scaleStandard Error 6.19
Cycling OnlySelf-reported Fatigue Using Modified Fatigue Impact Scale47.13 score on a scaleStandard Error 6.19
Secondary

Self-reported Fatigue Using Modified Fatigue Impact Scale

The Modified Fatigue Impact Scale is a 21 item self-report questionnaire that takes 5-10 minutes to complete. It uses a 5-point likert scale to rate the patient's perception of how Multiple Sclerosis related fatigue affects an individual's life on an everyday basis. It contains three subscales that include: cognitive, physical, and psychosocial dimensions. Scores on the subscales can be analyzed individually or as a summed score to give an overall fatigue score. Higher scores indicate a greater impact of fatigue. The minimum score is a 0 and the maximum score is 81.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
FES CyclingSelf-reported Fatigue Using Modified Fatigue Impact Scale32 score on a scaleStandard Error 6.19
Cycling OnlySelf-reported Fatigue Using Modified Fatigue Impact Scale39.57 score on a scaleStandard Error 6.19
Secondary

Self-reported Walking Using 12 Item Multiple Sclerosis Walking Scale

The Multiple Sclerosis Walking Scale is a 12-item self-report questionnaire that takes approximately 10 minutes to complete and reflects a persons' perception of the impact that multiple sclerosis has on walking ability during the past 2 weeks. Each of the items scored ranges from 1 to 5, in which higher scores indicate a greater impact of multiple sclerosis on their walking. Scores on the 12 items are summed. To transform to a 0-100 scale, the minimum score of 12 is subtracted from the sum; the result is divided by 48 and then multiplied by 100. The lowest score is 0 and the highest score is 100. Higher scores mean a worse outcome.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
FES CyclingSelf-reported Walking Using 12 Item Multiple Sclerosis Walking Scale64.43 score on a scaleStandard Error 6.78
Cycling OnlySelf-reported Walking Using 12 Item Multiple Sclerosis Walking Scale71.43 score on a scaleStandard Error 6.78
Secondary

Self-reported Walking Using 12 Item Multiple Sclerosis Walking Scale

The Multiple Sclerosis Walking Scale is a 12-item self-report questionnaire that takes approximately 10 minutes to complete and reflects a persons' perception of the impact that multiple sclerosis has on walking ability during the past 2 weeks. Each of the items scored ranges from 1 to 5, in which higher scores indicate a greater impact of multiple sclerosis on their walking. Scores on the 12 items are summed. To transform to a 0-100 scale, the minimum score of 12 is subtracted from the sum; the result is divided by 48 and then multiplied by 100. The lowest score is 0 and the highest score is 100. Higher scores mean a worse outcome.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
FES CyclingSelf-reported Walking Using 12 Item Multiple Sclerosis Walking Scale59.91 score on a scaleStandard Error 6.68
Cycling OnlySelf-reported Walking Using 12 Item Multiple Sclerosis Walking Scale69.52 score on a scaleStandard Error 6.78

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026